Cholinergic enzymatic activity of cerebrospinal fluid of patients with various neurologic diseases
dc.contributor.author | Johnson, S. | en_US |
dc.contributor.author | Domino, Edward F. | en_US |
dc.date.accessioned | 2006-04-17T16:20:10Z | |
dc.date.available | 2006-04-17T16:20:10Z | |
dc.date.issued | 1971-12 | en_US |
dc.identifier.citation | Johnson, S., Domino, E. F. (1971/12)."Cholinergic enzymatic activity of cerebrospinal fluid of patients with various neurologic diseases." Clinica Chimica Acta 35(2): 421-428. <http://hdl.handle.net/2027.42/33512> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6T57-47PRF20-1P3/2/d5c3bf819c0520830d055877d546f73c | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/33512 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=5125328&dopt=citation | en_US |
dc.description.abstract | The cerebrospinal fluid (CSF) of normal humans contains both true and pseudocholinesterases and choline acetyl transferase (choline acetylase) detectable by radiochemical assay. Elevations of total cholinesterase, pseudocholinesterase, and true cholinesterase occur in brain tumors, meningitis, Guillain-Barre disease, hydrocephalus, and brain abscess. However, the non-specificity and inconstancy of CSF cholinesterase changes in neurologic diseases limit its clinical usefulness.Choline acetylase levels in CSF are normally 0.187 +/- 0.073 nmoles ACh/ml CSF/ min. One patient with meningioma had a level of 0.680. Unlike cholinesterase, choline acetylase levels in blood are lower than in CSF. Hence, the origin of elevated CSF choline acetylase activity is probably in the nervous system. | en_US |
dc.format.extent | 641478 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Cholinergic enzymatic activity of cerebrospinal fluid of patients with various neurologic diseases | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Pathology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Pharmacology, University of Michigan, Ann Arbor and Lafayette Clinic, Detroit, Michigan, U.S.A. | en_US |
dc.contributor.affiliationum | Department of Pharmacology, University of Michigan, Ann Arbor and Lafayette Clinic, Detroit, Michigan, U.S.A. | en_US |
dc.identifier.pmid | 5125328 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/33512/1/0000010.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0009-8981(71)90216-6 | en_US |
dc.identifier.source | Clinica Chimica Acta | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.